Clinical Trials List
2016-12-23 - 2022-07-31
Phase I
Terminated2
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Wen-Pin Su Division of General Internal Medicine
- Sin-Syue Li Division of General Internal Medicine
- Yu-Min Yeh Division of General Internal Medicine
- Jui-Hung Tsai Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
- Chia-Jui Yen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
80 participants
